HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 306: | Line 306: | ||
|[[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] | |[[HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion|Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion]] | ||
|Disease | |Disease | ||
|Mayuri Shende (trainee) and Scott Turner (mentor)<br /> | |||
|9/22/24 | |||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 322: | Line 322: | ||
|[[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|Acute myeloid leukaemia with CBFB::MYH11 fusion]] | |[[HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion|Acute myeloid leukaemia with CBFB::MYH11 fusion]] | ||
|Disease | |Disease | ||
|Mayuri Shende (trainee) and Scott Turner (mentor)<br /> | |||
|9/22/24 | |||
| | | | ||
| | |Pending | ||
| | | | ||
|JH_MS | |JH_MS | ||
| Line 842: | Line 842: | ||
|[[HAEM5:Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion|Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | |[[HAEM5:Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion|Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | ||
|Disease | |Disease | ||
|Mayuri Shende (trainee) and Scott Turner (mentor)<br /> | |||
|9/22/24 | |||
| | | | ||
| | |Pending | ||
| | | | ||
|FQR | |FQR | ||
| Line 1,019: | Line 1,019: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS) ==== | ====CHAPTER 3 (HISTIOCYTIC/DENRITIC CELL NEOPLASMS)==== | ||
| | | | ||
----<br /> | ----<br /> | ||
| Line 1,258: | Line 1,258: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) ==== | ====CHAPTER 4 (B-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)==== | ||
| | | | ||
----<br /> | ----<br /> | ||
| Line 2,372: | Line 2,372: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS) ==== | ====CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)==== | ||
| | | | ||
----<br /> | ----<br /> | ||
| Line 2,841: | Line 2,841: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES) ==== | ====CHAPTER 6 (STROMA-DERIVED NEOPLASMS OF LYMPHOID TISSUES)==== | ||
| | | | ||
----<br /> | ----<br /> | ||
| Line 3,000: | Line 3,000: | ||
|- | |- | ||
| | | | ||
==== CHAPTER 7 (GENETIC TUMOUR SYNDROMES) ==== | ====CHAPTER 7 (GENETIC TUMOUR SYNDROMES)==== | ||
| | | | ||
----<br /> | ----<br /> | ||